Your browser doesn't support javascript.
loading
Characterizing the Links Between Systemic Sclerosis and Breast Cancer.
Dutt, Aditya; Arcinas, Lauren; Chen, Justin; Shaikh, Rahila; Jun, Sejoon; Kooner, Amritpal; Gandhi, Dhruv; Dolehide, Conor.
Afiliação
  • Dutt A; Dermatology, Midwestern University Chicago College of Osteopathic Medicine, Downers Grove, USA.
  • Arcinas L; Dermatology, Midwestern University Chicago College of Osteopathic Medicine, Downers Grove, USA.
  • Chen J; Dermatology, Midwestern University Chicago College of Osteopathic Medicine, Downers Grove, USA.
  • Shaikh R; Dermatology, University of Ottawa, Ottawa, CAN.
  • Jun S; Human Biology, Health, and Society, Cornell University, Ithaca, USA.
  • Kooner A; Dermatology, Walk-In Dermatology, Plainview, USA.
  • Gandhi D; Dermatology, Midwestern University Chicago College of Osteopathic Medicine, Downers Grove, USA.
  • Dolehide C; Medicine, K. J. Somaiya Medical College & Research Centre, Mumbai, IND.
Cureus ; 16(8): e66653, 2024 Aug.
Article em En | MEDLINE | ID: mdl-39262545
ABSTRACT
Systemic sclerosis (SSc) is a complex, autoimmune connective tissue disease that affects multiple organs in the body, culminating in a variance of severity and a reduced quality of life. Breast cancer (BC) also affects patients with SSc, and these two conditions affect a similar demographic. With this systematic review, we aim to characterize the links between SSc and BC. Characterizing possible links between SSc and breast malignancies is important for advancing the understanding of SSc management and comorbidities. In this systematic meta-analysis, a comprehensive literature search was conducted in PubMed using relevant keywords and MeSH terms. The inclusion criteria included an English-language retrospective analysis that characterized patients with SSc with or without BC. Two independent reviewers assessed the study's eligibility based on predetermined criteria. Data extraction included patient antibody measurements, demographics (age and gender), family history, social behaviors (alcohol use and smoking history), concurrent condition treatments, and adverse effects following treatment. Thirteen articles were identified in the literature with relevant data on SSc and BC patients. Studies encompassed research about SSc patients with or without BC and relevant risk factors being measured. SSc was found to have a link to antibodies widely associated with cancer. Adverse treatment outcomes and concurrent conditions of BC were found when patients had a family history of SSc, BC, or an alcohol or smoking history. Our results suggest that the presence of antinuclear antibodies, anti-centromere antibodies, or anti-topoisomerase antibodies in SSc patients is correlated with BC. Out of the three antibodies, ATA seemed to be found more commonly in patients with SSc and malignancy across the studies. This systematic review discusses the link between SSc and BC through patients with relevant clinical markers, medical histories, and treatments. However, further research is necessary to advance the linkage between SSc and BC and determine whether management of one condition may prevent or alleviate the other.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos